You appear to be offline. Some data may be unavailable until your connection is restored.

TECH

Stock

Bio-Techne Corp

Create price alert
$72.84
+$0.04 (0.05%)
At close: Nov 12, 2026, 4:00 PM

Description

Bio‑Techne Corp develops, manufactures and sells a broad range of life‑science reagents, analytical instruments and related services for research, clinical diagnostics and bioprocessing markets worldwide. Its product portfolio includes antibodies, recombinant proteins, ELISA and Luminex assay kits, cell‑culture media and precision diagnostic tools that support drug‑discovery, biomarker development and molecular testing. The company operates within the biotechnology and healthcare equipment sector, serving academic institutions, pharmaceutical companies and clinical laboratories. Bio‑Techne is recognized as a leading supplier of high‑quality research tools, leveraging a strong brand portfolio and extensive application expertise to maintain a competitive position across multiple product categories.

Quarterly Earnings

QuarterDateEPS
Q1 FY27Nov 13, 2026 (est.)—
Q4 FY26Aug 12, 2026$0.49
Q3 FY26May 6, 2026$0.53
Q2 FY26Feb 4, 2026$0.46
Q1 FY26Nov 5, 2025$0.36

Stay ahead of TECH earnings

Get reminders ahead of TECH's next earnings report, so you always know when results are coming.

Other Healthcare stocks in the S&P 500